Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Novadaq's OPTTX for AMD (age-related macular degeneration):

This article was originally published in Clinica

Executive Summary

Novadaq Technologies has CE-marked for sale in Europe what it claims is the first commercially available tool that can diagnose, treat and manage wet age-related macular degeneration (AMD) in a single device. The OPTTX system produces ultra high-speed indocyanine green angiograms and facilitates the identification of choroidal feeder vessels (FVs). It also allows the physician to view a real-time angiogram, in which a treatment laser is able to track and fire precisely while the FV is visible. It then enables the physician to immediately confirm the effectiveness of the treatment. Conventional feeder vessel therapy for the condition uses two medical devices, one for imaging, and the second for treatment, explained the Toronto, Canada firm. Novadaq is conducting a limited launch of the OPTTX system, and plans full commercialisation in the second quarter of 2007.

You may also be interested in...



ECHA Deliberates On Final Microplastic Proposal As Beauty Industry’s Fate Hangs In Balance

A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.

QUOTED. 2 December. Laurent Faracci.

Butterfly Network’s CEO Laurent Faracci outlines the company’s growth strategy and plans for their “ultrasound-on-a-chip” technology after its merger with blank check company Longview Acquisition Corp. See what the company’s CEO said about it here.

Health Care Personnel, Long-Term Care Residents Should Get COVID-19 Vaccine First, ACIP Votes

CDC’s Advisory Committee on Immunization Practices votes 13-1 that these two groups be first in line for vaccination once FDA authorizes a vaccine and ACIP recommends it. Goal of vote is to guide health departments in placing vaccine orders.

Topics

UsernamePublicRestriction

Register

OM009163

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel